|
시장보고서
상품코드
2088910
오픈 MRI 시스템 시장 : 구성부품별, 자장 강도별, 촬상 모드별, 용도별, 최종 사용자별 예측(2026-2032년)Open MRI Systems Market by Component, Field Strength, Imaging Mode, Application, End Users - Global Forecast 2026-2032 |
||||||
360iResearch
오픈 MRI 시스템 시장은 2032년까지 연평균 복합 성장률(CAGR) 8.45%로 31억 2,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 : 2025년 | 17억 7,000만 달러 |
| 추정 연도 : 2026년 | 19억 1,000만 달러 |
| 예측 연도 : 2032년 | 31억 2,000만 달러 |
| CAGR(%) | 8.45% |
오픈 MRI 시스템은 밀실공포증이 있는 분, 체격이 큰 분, 운동 기능에 제한이 있는 분, 소아 환자, 또는 정형외과나 중재적 검사 시 체위 조정이 필요한 환자 등, 기존의 밀폐형 스캐너로는 검사를 받기 어려울 수 있는 환자들이 자기공명영상(MRI) 검사를 더 쉽게 받을 수 있도록 설계되었습니다. 컴퓨터 단층촬영(CT)이나 X선 영상 진단과 달리, MRI는 전리 방사선을 사용하지 않기 때문에 신경 영상 진단, 근골격계 영상 진단, 종양학적 검사, 심혈관 평가 및 경과 관찰에서 계속해서 중요한 역할을 하고 있습니다.
오픈 MRI 시스템경쟁 구도는 환자의 편안함과 영상 품질이라는 기존의 상충 관계라는 틀을 넘어 변화하고 있습니다. 저자기장 및 중자기장 오픈 MRI 스캐너는 비용이나 접근성을 중시하는 환경에서 여전히 중요한 역할을 하고 있지만, 자석 설계, 그라디언트 성능, 코일 기술 및 재구성 소프트웨어의 발전으로 인해 환자에게 더 사용하기 편리한 스캐너 구성의 임상적 가치가 높아지고 있습니다.
인공지능(AI)은 오픈 MRI의 전체 밸류체인에 누적적인 효과를 가져오고 있습니다. 이미지 획득 과정에서 AI를 활용한 재구성, 노이즈 제거 및 움직임 보정을 통해 스캔 시간을 단축하고 이미지의 일관성을 높일 수 있습니다. 이는 불안을 느끼는 환자나 가만히 있는 것이 어려운 환자에게 특히 중요합니다. 동료 심사를 거친 방사선 의학 문헌에 따르면, 특정 MRI 용도에서 딥러닝을 활용한 재구성이 진단적 유용성을 유지할 수 있는 것으로 나타났으나, 임상적 검증, 규제 당국의 승인 및 각 기관별 프로토콜 관리는 여전히 필수적입니다.
아시아태평양은 일본, 중국, 한국, 호주의 방대한 환자 수, 확대되는 민간 병원 네트워크, 건강보험 보급률의 상승, 그리고 현저한 고령화 추세로 인해 오픈 MRI 시스템에 있어 큰 잠재력을 지닌 지역입니다. OECD 자료에 따르면, 일본은 꾸준히 MRI 설치 밀도가 가장 높은 국가 중 하나로 꼽히고 있는 반면, 중국과 인도에서는 주요 도시 이외 지역의 접근성을 높이기 위해 진단 인프라 확충이 계속되고 있습니다. 이러한 시장에서는 환자의 편의성에 대한 요구, 근골격계 영상 진단 수요, 그리고 외래 진단 역량의 확대가 오픈 MRI 도입을 촉진하고 있습니다.
아세안 시장은 민간 병원 그룹, 의료 관광 회랑, 그리고 공중보건 인프라에 대한 투자를 통해 확대되고 있으며, 접근성과 환자의 편의성이 우선시되는 이 지역에서 콤팩트하고 서비스 효율성이 뛰어난 오픈 MRI 시스템이 주목을 받고 있습니다. GCC 지역은 각국의 의료 혁신 프로그램, 고도 급성기 병원의 개발, 전문 의료, 의료 관광, 그리고 고품질의 환자 경험을 뒷받침하는 첨단 영상 진단 플랫폼에 대한 수요에 의해 형성되고 있습니다.
미국은 FDA 규제 하에서의 혁신, 외래 영상 진단센터, 대학 병원, 그리고 밀실공포증 환자, 비만 환자, 소아 환자 및 이동에 제약이 있는 환자를 지원하는 환자 친화적인 MRI에 대한 강력한 수요에 힘입어 시장을 선도하고 있습니다. 캐나다는 주 정부 차원의 조달, 공공 의료 기관의 대기 시간 단축을 위한 노력, 그리고 지역별로 불균등한 영상 진단 접근 현황이 특징입니다. 한편, 멕시코에서는 민간 병원의 확대와 도시 지역의 진단 수요가 맞물려 시장을 형성하고 있습니다. 브라질의 관민 병용 시스템은 주요 도시의 MRI 현대화를 뒷받침하고 있지만, 보험 환급 조건, 수입 비용 및 서비스 이용 가능성은 여전히 큰 영향을 미치고 있습니다.
업계 리더는 오픈 MRI 시스템을 단순히 폐소공포증 환자를 위한 대안으로만 간주하지 말고, 임상적으로 입증된 영상 품질, 환자의 편안함, 그리고 업무 흐름의 효율성을 우선시해야 합니다. 제품 로드맵에서는 프로토콜의 고속화, AI를 활용한 재구성, 유지보수 부담이 적은 자석 아키텍처, 원격 진단, 사이버 보안, 에너지 효율, 그리고 기존 영상의학과 IT 생태계와의 호환성을 중시해야 합니다.
본 요약본은 의료 기술 평가에 사용되는 삼각측량법에 기반한 1차 조사 및 2차 조사 기법을 바탕으로 작성되었습니다. 정보 출처에는 규제 데이터베이스, 의료기기 관련 지침, 동료 심사를 거친 방사선 의학 문헌, WHO, 유엔, OECD 등 기관이 제공하는 공중보건 데이터 세트, 병원의 조달 패턴, 보험 급여 기준, 공공 정책 문서, 그리고 진단 영상의 동향에 대한 전문가의 해석이 포함됩니다.
의료 서비스 제공업체들이 환자의 접근성, 영상 품질, 운영 효율성, 그리고 자본 규율 간의 균형을 모색함에 따라, 오픈 MRI 시스템 시장은 더욱 전략적인 단계로 접어들고 있습니다. 수요는 고령화, 만성 질환으로 인한 부담, 외래 진료의 확대, 그리고 폐쇄형 MRI 환경에 적합하지 않은 환자에 대한 대응 필요성에 의해 뒷받침되고 있습니다.
The Open MRI Systems Market is projected to grow by USD 3.12 billion at a CAGR of 8.45% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.77 billion |
| Estimated Year [2026] | USD 1.91 billion |
| Forecast Year [2032] | USD 3.12 billion |
| CAGR (%) | 8.45% |
Open MRI systems are designed to improve access to magnetic resonance imaging for patients who may not tolerate conventional closed-bore scanners, including individuals with claustrophobia, larger body habitus, mobility limitations, pediatric needs, or positioning requirements for orthopedic and interventional evaluation. Unlike computed tomography or X-ray imaging, MRI does not use ionizing radiation, supporting its continued role in neuroimaging, musculoskeletal imaging, oncology workups, cardiovascular assessment, and follow-up care.
The open MRI systems market is being shaped by three verified demand drivers: aging populations documented by the United Nations, rising chronic disease and musculoskeletal burden tracked by the World Health Organization, and uneven MRI equipment density reported across countries by OECD health statistics. Hospitals, diagnostic imaging centers, and specialty clinics are evaluating open magnetic resonance imaging platforms not only for patient comfort, but also for throughput, operating cost, image quality, serviceability, and integration with digital radiology workflows.
The competitive landscape for open MRI systems is moving beyond the historic trade-off between patient comfort and image quality. Low-field and mid-field open MRI scanners remain relevant for cost-sensitive and access-focused settings, while advances in magnet design, gradient performance, coil technology, and reconstruction software are improving the clinical value of more patient-friendly scanner configurations.
Procurement priorities are also shifting. Buyers increasingly evaluate total cost of ownership, installation footprint, energy consumption, remote service capabilities, cybersecurity, and compatibility with PACS, RIS, electronic health records, and cloud-based image exchange. The transition toward outpatient imaging, value-based care, and community diagnostic access is strengthening demand for MRI systems that can reduce exam abandonment, improve scheduling flexibility, and support safer scanning for a wider patient population.
Artificial intelligence is creating a cumulative effect across the open MRI value chain. In image acquisition, AI-assisted reconstruction, denoising, and motion correction can help shorten scan times and improve image consistency, which is especially important for anxious patients and individuals who struggle to remain still. Peer-reviewed radiology literature has shown that deep learning reconstruction can preserve diagnostic utility in selected MRI applications, although clinical validation, regulatory clearance, and site-specific protocol governance remain essential.
AI is also influencing workflow economics. Automated patient positioning, protocol recommendation, quality control, scan prioritization, report drafting support, and predictive maintenance can reduce operational friction in diagnostic imaging departments. For open MRI vendors, the strategic opportunity is not merely to add algorithms, but to deliver validated, auditable, cybersecurity-ready AI capabilities that integrate with radiologist workflows and comply with FDA, EU MDR, and local medical-device regulations.
Asia-Pacific is a high-potential region for open MRI systems due to large patient populations, expanding private hospital networks, rising health insurance penetration, and significant aging trends in Japan, China, South Korea, and Australia. OECD data consistently shows Japan among the countries with the highest MRI unit density, while China and India continue to expand diagnostic infrastructure to improve access beyond top-tier cities. In these markets, open MRI adoption is supported by patient comfort needs, musculoskeletal imaging demand, and the expansion of outpatient diagnostic capacity.
North America remains a leading region because of its mature radiology ecosystem, high adoption of outpatient imaging, advanced reimbursement frameworks, and strong replacement demand for MRI scanners. The United States and Canada also show sustained interest in patient-centered imaging models that reduce claustrophobia-related exam interruption and improve care access. Latin America is driven by private diagnostic chains, hospital modernization, and urban imaging demand in Brazil and Mexico, although public-sector budget constraints, import dependence, and service coverage gaps can slow broader open MRI adoption.
Europe benefits from universal health systems, established radiology standards, and demand for patient-centered imaging, but procurement is influenced by EU MDR compliance, energy efficiency, data protection, and regional tender cycles. The Middle East, particularly GCC countries, is investing in hospital capacity, specialty care, and medical tourism, strengthening demand for advanced and reliable MRI infrastructure. Africa remains underpenetrated in MRI access according to global imaging availability assessments, making affordability, uptime, workforce training, and local service networks decisive for open MRI deployment.
ASEAN markets are expanding through private hospital groups, medical tourism corridors, and public health infrastructure investment, making compact and service-efficient open MRI systems attractive where access and patient comfort are priorities. The GCC is shaped by national health transformation programs, high-acuity hospital development, and demand for advanced imaging platforms that support specialty care, medical tourism, and premium patient experience.
The European Union emphasizes regulatory compliance, cross-border device standards, sustainability, and data protection under frameworks such as EU MDR and GDPR, encouraging suppliers to demonstrate lifecycle safety, software governance, and interoperability. BRICS countries are important because they combine large patient bases with policy interest in local manufacturing, cost containment, and wider diagnostic access. These markets often require flexible financing, robust service models, and systems suited to diverse hospital environments.
G7 markets represent mature demand for replacement systems, AI-enabled workflow, lower operating burden, and evidence-based procurement tied to radiology productivity and patient outcomes. NATO countries are not a commercial bloc, but their health systems, military hospitals, and supply-chain resilience priorities reinforce demand for reliable, secure, and serviceable imaging infrastructure. Across these groups, successful open MRI strategies depend on aligning system performance with regulatory expectations, procurement discipline, and healthcare access goals.
The United States leads through FDA-regulated innovation, outpatient imaging centers, academic hospitals, and strong demand for patient-friendly MRI that supports claustrophobic, bariatric, pediatric, and mobility-limited patients. Canada is shaped by provincial procurement, public wait-time reduction initiatives, and geographically uneven imaging access, while Mexico combines private hospital expansion with urban diagnostic demand. Brazil's dual public-private system supports MRI modernization in major cities, though reimbursement conditions, import costs, and service availability remain influential.
In Europe, the United Kingdom is investing in diagnostic capacity through NHS recovery programs and community diagnostic models, strengthening interest in accessible MRI solutions. Germany benefits from a dense specialist care network and strong imaging utilization, France from national insurance coverage and structured hospital procurement, Italy and Spain from regional healthcare purchasing and modernization needs, and Russia from import substitution policies and supply-chain complexity that can influence technology availability and maintenance planning.
In Asia-Pacific, China emphasizes domestic medical-device development, hospital expansion, and broader access to advanced diagnostics; India is scaling imaging through private diagnostic chains, tertiary hospitals, and public insurance initiatives; and Japan's super-aging population sustains high MRI utilization documented in OECD equipment statistics. Australia relies on Medicare-supported imaging access and a mix of hospital and independent radiology providers, while South Korea combines advanced hospitals, high digital health adoption, and strong demand for efficient imaging workflows. Across these countries, open MRI system adoption is tied to patient comfort, scan completion, clinical confidence, uptime, and integration with radiology IT infrastructure.
Industry leaders should prioritize clinically validated image quality, patient comfort, and workflow efficiency rather than positioning open MRI systems only as alternatives for claustrophobic patients. Product roadmaps should emphasize faster protocols, AI-assisted reconstruction, low-maintenance magnet architecture, remote diagnostics, cybersecurity, energy efficiency, and compatibility with established radiology IT ecosystems.
Commercial strategies should be localized. Mature markets need replacement-cycle value, reimbursement evidence, cybersecurity assurance, and integration with outpatient imaging operations. Emerging markets require financing options, training programs, service uptime guarantees, and scalable installation models. Vendors that document total cost of ownership, exam completion rates, patient satisfaction, diagnostic performance, and protocol consistency will be better positioned in hospital tenders and private imaging network decisions.
This executive summary is based on triangulated secondary and primary research methods used in healthcare technology assessment. Inputs include regulatory databases, medical-device guidance, peer-reviewed radiology literature, public health datasets from organizations such as WHO, UN, and OECD, hospital procurement patterns, reimbursement references, public policy documents, and expert interpretation of diagnostic imaging trends.
The methodology emphasizes verifiable evidence over speculative claims. Market drivers were evaluated through installed-base indicators, demographic demand, technology adoption, clinical use cases, regulatory context, and regional healthcare infrastructure. AI-related conclusions were limited to validated workflow and image-processing applications with recognized requirements for clinical testing, governance, cybersecurity, and medical-device compliance.
The open MRI systems market is entering a more strategic phase as healthcare providers balance patient access, imaging quality, operational efficiency, and capital discipline. Demand is supported by aging populations, chronic disease burden, expanding outpatient diagnostics, and the need to serve patients who are poorly suited to closed-bore MRI environments.
Future progress will depend on vendors' ability to prove clinical performance, integrate AI responsibly, reduce lifecycle cost, and provide dependable service across both mature and emerging markets. Organizations that align open MRI innovation with patient-centered care, radiology workflow productivity, regulatory compliance, and evidence-based procurement will be best positioned to strengthen long-term adoption.